208 related articles for article (PubMed ID: 3892701)
1. The combined use of cytosine arabinoside, cyclophosphamide, and total body irradiation as preparative regimen for bone marrow transplantation in patients with AML and CML.
Messner HA; Curtis JE; Minden MM
Semin Oncol; 1985 Jun; 12(2 Suppl 3):187-9. PubMed ID: 3892701
[No Abstract] [Full Text] [Related]
2. High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.
Champlin R; Jacobs A; Gale RP; Ho W; Selch M; Lenarsky C; Feig SA
Semin Oncol; 1985 Jun; 12(2 Suppl 3):190-5. PubMed ID: 3892702
[No Abstract] [Full Text] [Related]
3. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.
Herzig RH; Coccia PF; Lazarus HM; Strandjord SE; Graham-Pole J; Cheung NK; Gordon EM; Gross S; Spitzer TR; Warkentin PI
Semin Oncol; 1985 Jun; 12(2 Suppl 3):184-6. PubMed ID: 3892700
[No Abstract] [Full Text] [Related]
4. High-dose etoposide, cyclophosphamide, and total body irradiation with allogeneic bone marrow transplantation for patients with acute myeloid leukemia in untreated first relapse: a study by the North American Marrow Transplant Group.
Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
Blood; 1995 Mar; 85(5):1391-5. PubMed ID: 7858269
[TBL] [Abstract][Full Text] [Related]
5. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
6. High-dose etoposide, cyclophosphamide and total body irradiation with allogeneic bone marrow transplantation for resistant acute myeloid leukemia: a study by the North American Marrow Transplant Group.
Brown RA; Wolff SN; Fay JW; Pineiro L; Collins RH; Lynch JP; Stevens D; Greer J; Herzig RH; Herzig GP
Leuk Lymphoma; 1996 Jul; 22(3-4):271-7. PubMed ID: 8819076
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).
Ratanatharathorn V; Karanes C; Lum LG; Uberti J; Dan ME; de Planque MM; Schultz KR; Cronin S; Leisz MC; Mohamed A
Bone Marrow Transplant; 1992 Jan; 9(1):49-55. PubMed ID: 1543949
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation: its biology and role as treatment for acute and chronic leukemias.
Champlin R; Gale RP
Ann N Y Acad Sci; 1987; 511():447-58. PubMed ID: 2830829
[No Abstract] [Full Text] [Related]
9. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
Stein AS; O'Donnell MR; Chai A; Schmidt GM; Nademanee A; Parker PM; Smith EP; Snyder DS; Molina A; Stepan DE; Spielberger R; Somlo G; Margolin KA; Vora N; Lipsett J; Lee J; Niland J; Forman SJ
J Clin Oncol; 1996 Aug; 14(8):2206-16. PubMed ID: 8708709
[TBL] [Abstract][Full Text] [Related]
10. Sequential Intensified Conditioning Regimen Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Intermediate- or High-Risk Acute Myeloid Leukemia in Complete Remission: A Study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Malard F; Labopin M; Stuhler G; Bittenbring J; Ganser A; Tischer J; Michallet M; Kröger N; Schmid C; Huynh A; Hallek M; Savani BN; Mohty M; Nagler A
Biol Blood Marrow Transplant; 2017 Feb; 23(2):278-284. PubMed ID: 27816650
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
12. [Bone marrow transplantation after preoperative chemotherapy and total body irradiation. III. Case report].
Sułek K; Kłos M; Jarczewska M; Federowicz I; Nowak J; Carewicz R; Dańczak-Ginalska Z; Meder J; Kukołowicz P; Czermińska M
Nowotwory; 1986; 36(4):280-7. PubMed ID: 3299276
[No Abstract] [Full Text] [Related]
13. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
14. Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation.
Trigg ME; Finlay JL; Bozdech M; Gilbert E
Cancer; 1987 Jan; 59(1):38-42. PubMed ID: 3539307
[TBL] [Abstract][Full Text] [Related]
15. Non-supralethal mitobronitol/cytarabine/cyclophosphamide conditioning without irradiation before bone marrow transplantation for accelerated chronic granulocytic leukemia: apparent absence of acute graft-versus-host disease.
Kelemen E; Jakab K; Váradi G; Jánossa M; Földi J; Dénes R
Leukemia; 1993 Jul; 7(7):939-45. PubMed ID: 8321045
[TBL] [Abstract][Full Text] [Related]
16. High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
Riddell S; Appelbaum FR; Buckner CD; Stewart P; Clift R; Sanders J; Storb R; Sullivan K; Thomas ED
J Clin Oncol; 1988 Apr; 6(4):576-82. PubMed ID: 3282031
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse.
Blaise D; Maraninchi D; Archimbaud E; Reiffers J; Devergie A; Jouet JP; Milpied N; Attal M; Michallet M; Ifrah N
Blood; 1992 May; 79(10):2578-82. PubMed ID: 1586710
[TBL] [Abstract][Full Text] [Related]
18. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.
Michel G; Gluckman E; Esperou-Bourdeau H; Reiffers J; Pico JL; Bordigoni P; Thuret I; Blaise D; Bernaudin F; Jouet JP
J Clin Oncol; 1994 Jun; 12(6):1217-22. PubMed ID: 8201385
[TBL] [Abstract][Full Text] [Related]
20. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.
Coccia PF; Strandjord SE; Warkentin PI; Cheung NK; Gordon EM; Novak LJ; Shina DC; Herzig RH
Blood; 1988 Apr; 71(4):888-93. PubMed ID: 3281725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
